Annual ROE:
-17.90%+16.89%(+48.55%)Summary
- As of today, VKTX annual return on equity is -17.90%, with the most recent change of +16.89% (+48.55%) on December 31, 2024.
- During the last 3 years, VKTX annual ROE has risen by +6.75% (+27.38%).
- VKTX annual ROE is now -117.00% below its all-time high of 105.31%, reached on December 31, 2012.
Performance
VKTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-19.70%-5.43%(-38.05%)Summary
- As of today, VKTX quarterly return on equity is -19.70%, with the most recent change of -5.43% (-38.05%) on June 30, 2025.
- Over the past year, VKTX quarterly ROE has dropped by -3.34% (-20.42%).
- VKTX quarterly ROE is now -107.58% below its all-time high of 259.95%, reached on June 30, 2015.
Performance
VKTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VKTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +48.5% | -20.4% |
| 3Y3 Years | +27.4% | +34.2% |
| 5Y5 Years | -99.5% | -67.5% |
VKTX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +54.9% | -43.2% | +57.6% |
| 5Y | 5-Year | -99.5% | +54.9% | -47.1% | +57.6% |
| All-Time | All-Time | -117.0% | +93.3% | -107.6% | +99.5% |
VKTX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -19.70%(-38.1%) |
| Mar 2025 | - | -14.27%(-3.7%) |
| Dec 2024 | -17.90%(+48.5%) | -13.76%(+3.3%) |
| Sep 2024 | - | -14.23%(+13.0%) |
| Jun 2024 | - | -16.36%(+24.2%) |
| Mar 2024 | - | -21.59%(+30.5%) |
| Dec 2023 | -34.79%(+12.3%) | -31.07%(+8.9%) |
| Sep 2023 | - | -34.11%(+9.6%) |
| Jun 2023 | - | -37.72%(+18.8%) |
| Mar 2023 | - | -46.45%(-14.1%) |
| Dec 2022 | -39.67%(-60.9%) | -40.70%(-20.6%) |
| Sep 2022 | - | -33.74%(-12.7%) |
| Jun 2022 | - | -29.94%(-11.1%) |
| Mar 2022 | - | -26.94%(-9.9%) |
| Dec 2021 | -24.65%(-62.7%) | -24.52%(-7.4%) |
| Sep 2021 | - | -22.83%(-12.5%) |
| Jun 2021 | - | -20.30%(-17.3%) |
| Mar 2021 | - | -17.31%(-14.4%) |
| Dec 2020 | -15.15%(-68.9%) | -15.13%(-13.0%) |
| Sep 2020 | - | -13.39%(-13.9%) |
| Jun 2020 | - | -11.76%(-8.7%) |
| Mar 2020 | - | -10.82%(-21.0%) |
| Dec 2019 | -8.97% | -8.94%(-11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -8.04%(+13.0%) |
| Jun 2019 | - | -9.24%(+12.7%) |
| Mar 2019 | - | -10.58%(+20.7%) |
| Dec 2018 | -14.18%(+92.6%) | -13.35%(+32.2%) |
| Sep 2018 | - | -19.70%(+54.6%) |
| Jun 2018 | - | -43.37%(+53.0%) |
| Mar 2018 | - | -92.27%(+66.0%) |
| Dec 2017 | -191.35%(-8.9%) | -271.71%(+6.6%) |
| Sep 2017 | - | -290.82%(-47.3%) |
| Jun 2017 | - | -197.49%(-7.1%) |
| Mar 2017 | - | -184.46%(-14.0%) |
| Dec 2016 | -175.71%(+34.5%) | -161.74%(-1.5%) |
| Sep 2016 | - | -159.33%(-7.9%) |
| Jun 2016 | - | -147.62%(+76.0%) |
| Mar 2016 | - | -614.31%(+24.2%) |
| Dec 2015 | -268.24%(-371.2%) | -810.52%(+81.4%) |
| Sep 2015 | - | -4364.00%(-1778.8%) |
| Jun 2015 | - | 259.95%(+133.1%) |
| Mar 2015 | - | 111.53%(-42.5%) |
| Dec 2014 | 98.90%(+66.5%) | - |
| Jun 2014 | - | 193.89%(+345.7%) |
| Mar 2014 | - | 43.50% |
| Dec 2013 | 59.41%(-43.6%) | - |
| Dec 2012 | 105.31% | - |
FAQ
- What is Viking Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual ROE year-on-year change?
- What is Viking Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly ROE year-on-year change?
What is Viking Therapeutics, Inc. annual return on equity?
The current annual ROE of VKTX is -17.90%
What is the all-time high annual ROE for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual return on equity is 105.31%
What is Viking Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, VKTX annual return on equity has changed by +16.89% (+48.55%)
What is Viking Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of VKTX is -19.70%
What is the all-time high quarterly ROE for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly return on equity is 259.95%
What is Viking Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, VKTX quarterly return on equity has changed by -3.34% (-20.42%)